Coming Soon: Free, Online Alport syndrome CME
The Alport syndrome Foundation is proud to sponsor a one-hour free accredited CME that will focus on the fundamentals of Alport syndrome, including diagnosis, treatment, and management of the disease. Doctors and nurses will receive one (1) CE upon completion of the course.
More information on this upcoming CME program will be announced by the end of 2017.
Dr. Clifford Kashtan is the Director of Pediatric Nephrology at the University of Minnesota. He is also the Co-Director of the Alport syndrome Treatments and Outcomes Registry (ASTOR), which is the US patient registry, and a member of the Alport syndrome Foundation’s Medical Advisory Committee. Dr. Kashtan has served as a consultant to Reata Pharmaceuticals and is an investigator in the CARDINAL clinical trial sponsored by Reata.
We thank the following additional sponsor for their support of this program:
The Alport syndrome Foundation is the leading independent, nonprofit organization in the United States serving and giving a voice to the Alport syndrome community. ASF’s mission is to improve the lives of patients through education, empowerment, advocacy, and research to realize the vision of conquering Alport syndrome.